KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Return on Assets (2016 - 2025)

Historic Return on Assets for Inovio Pharmaceuticals (INO) over the last 17 years, with Q3 2025 value amounting to 1.26%.

  • Inovio Pharmaceuticals' Return on Assets fell 3200.0% to 1.26% in Q3 2025 from the same period last year, while for Sep 2025 it was 1.26%, marking a year-over-year decrease of 3200.0%. This contributed to the annual value of 0.76% for FY2024, which is 2400.0% down from last year.
  • As of Q3 2025, Inovio Pharmaceuticals' Return on Assets stood at 1.26%, which was down 3200.0% from 1.19% recorded in Q2 2025.
  • Inovio Pharmaceuticals' Return on Assets' 5-year high stood at 0.22% during Q2 2021, with a 5-year trough of 1.26% in Q3 2025.
  • For the 5-year period, Inovio Pharmaceuticals' Return on Assets averaged around 0.77%, with its median value being 0.78% (2022).
  • Per our database at Business Quant, Inovio Pharmaceuticals' Return on Assets soared by 3500bps in 2021 and then plummeted by -5600bps in 2022.
  • Inovio Pharmaceuticals' Return on Assets (Quarter) stood at 0.59% in 2021, then decreased by -28bps to 0.75% in 2022, then increased by 1bps to 0.74% in 2023, then plummeted by -32bps to 0.98% in 2024, then dropped by -29bps to 1.26% in 2025.
  • Its last three reported values are 1.26% in Q3 2025, 1.19% for Q2 2025, and 1.02% during Q1 2025.